RBC Capital Reinstates Outperform on Repligen, Announces $160 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 47.4%

Neg 0% Neu 47.4% Pos 0%

RBC Capital analyst Dan Leonard reinstates Repligen (NASDAQ:RGEN) with a Outperform and announces $160 price target.

Comments

No comments yet. Be the first!